I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Methicillin-resistant coagulase-negative staphylococci (MR-CoNS) are Gram-positive bacteria considered to be opportunistic pathogens that cause nosocomial and community-acquired infections, including skin and tissue infections, pneumonia, endocarditis, and septicemia.\[[@ref1]\] To date, the prevalence of MR-CoNS infections worldwide ranges from 20% to 30% and can be isolated from various clinical samples, such as blood, sputum, urine, and pus.\[[@ref2]\] Among MR-CoNS, *Staphylococcus epidermidis*, and *Staphylococcus haemolyticus* have become the two major causes of nosocomial infections, which are difficult to treat with antimicrobial agents owing to their capacity to form biofilms on implant medical devices.\[[@ref3]\] Staphylococcal infections can be treated with antimicrobial agents, but most bacteria strains have developed resistance to methicillin and most beta-lactam antibiotics.\[[@ref4]\] The resistance to methicillin and other beta-lactam antibiotics in both MR *Staphylococcus aureus* and MR-CoNS is primarily caused by the acquisition of the *mec* A gene, which encodes a modified penicillin-binding protein 2a that has a low binding affinity for all beta-lactam antibiotics.\[[@ref5][@ref6]\]

Slime or biofilm formation permits microorganisms to adhere to different materials, such as prostheses and intravenous devices.\[[@ref7]\] Cells within the biofilm are highly resistant to sanitation procedures. The interaction of the host immune system with antimicrobial agents and the development of the biofilm begins with the bacteria adhering to a biotic or an abiotic surface mediated by microbial surface components that recognize adhesive matrix molecules.\[[@ref8]\] The bacteria then multiply to form a multilayered biofilm, and this is associated with the production of the polysaccharide intracellular adhesion (PIA) protein, which mediates cell-to-cell adhesion.\[[@ref1]\] Three major proteins that play an important role in biofilm development are PIA, biofilm-associated protein (Bap), and fibronectin binding protein (FnbA). PIA is encoded by *ica*ABCD genes located within the intracellular adhesion (ica) operon, and *Bap* is encoded by *bap* gene involved in initial attachment and ica.\[[@ref9][@ref10][@ref11]\] In addition, *fnb*A plays an important role in the accumulation phase of biofilm formation either through homophilic interactions or through binding of the proteins to surface receptors of adjacent cells.\[[@ref12]\] The distinct nature of species clusters was suspected to be the cause of this difference.\[[@ref13]\] Therefore, the process of biofilm formation of MR-CoNS isolated from different sources of clinical specimens should be studied. In the present study, we detected an association between antimicrobial resistance and biofilm formation in different phenotypes of MR-CoNS isolated from various clinical specimens. Understanding the virulence of pathogen biofilms is essential for finding new strategies to lower the severity and prevalence of infectious diseases.

M[ATERIALS AND]{.smallcaps} M[ETHODS]{.smallcaps} {#sec1-2}
=================================================

Samples {#sec2-1}
-------

A total of 55 clinical isolates of MR-CoNS were obtained. Of which 31 clinical isolates were collected from patients who were admitted to Chiangrai Prachanukroh hospital, and 24 isolates were obtained from patients hospitalized in Naresuan University Hospital. The Chiangrai Prachanukroh Hospital is located in the upper northern region of Thailand, and the Naresuan University Hospital is located in the lower northern region of Thailand. The clinical samples were collected between November 2014 and October 2015. All MR-CoNS isolates were collected from blood (80%), pus (7.3%), and other body fluid (12.7%) samples.

Species identification of methicillin-resistant staphylococci {#sec2-2}
-------------------------------------------------------------

The bacteria were initially identified by colony morphology, mannitol fermentation, Gram characteristics, catalase, coagulase test, and DNase activity. All isolates were subsequently confirmed as staphylococci by PCR using 16S RNA primers specific to staphylococci.\[[@ref14]\] Cefoxitin disk (30 μg) on Mueller-Hinton agar and detection of *mec*A gene by PCR method was performed to confirm the methicillin resistance. The direct MALDI-TOF-MS was carried out to distinguish the species level of MR-CoNS. Briefly, several colonies were harvested from Mueller-Hinton agar and suspended in 100 μl of sterile water. 1 μl of this mixture was then deposited on a target plate (Bruker Daltonics, Germany) in two replicates and allowed to dry at room temperature. One microliter of absolute ethanol (Merck, Darmstadt, Germany) was then added to each well and dried at room temperature. Subsequently, 1 μl of matrix, α-cyano-4-hydroxycinnamic acid (Bruker Daltonics, Germany) dissolved in a solution of 50% acetonitrile, 2.5% trifluoroacetic acid, and 47.5% water (Sigma-Aldrich, Fluka, MO, USA). MALDI-TOF-MS Spectrometer Autoflex speed (Bruker Daltonics, Germany) and FlexControl software (version 3.4.135, Bruker Daltonics, Germany) were processed to detect the protein and identified the difference between species. A score of 2.000--3.000 indicated species-level identification. The score from 1.700--1.999 indicated genus-level identification and a score of \<1.700 was an unreliable identification.\[[@ref15]\] The sequencing of *tuf* genes was used to confirm the species level of isolates that could not be identified directly through MALDI-TOF MS.\[[@ref16]\]

Determination of antimicrobial susceptibility pattern {#sec2-3}
-----------------------------------------------------

Disc diffusion tests were performed with the following 15 antibiotics (Oxoid, Basingstoke, England): Penicillin (P, 10 units), clindamycin (DA; 2 μg), chloramphenicol (C; 30 μg), gentamicin (CN; 10 μg), erythromycin (E; 15 μg), cefoxitin (FOX; 30 μg), oxacillin (OX; 1 μg), sulfamethoxazole/trimethoprim (SXT; 1.25/23.75 μg), vancomycin (VA; 30 μg), rifampicin (RD; 5 μg), linezolid (LZD; 30 μg), mupirocin (MUP; 5 μg), ciprofloxacin (CIP; 5 μg), fusidic acid (FD; 10 μg), and novobiocin (NV; 5 μg). The results were interpreted according to Clinical and Laboratory Standards Institute guidelines.\[[@ref17]\]

Phenotypic biofilm assay {#sec2-4}
------------------------

Congo red agar (CRA) test was performed to determine slime production. All MR-CoNS isolates were inoculated on the CRA plate and incubated at 35°C under aerobic conditions for 24--48 h. The slime production was characterized by the color change of the colonies from red to black color. The colonies that remain red were classified as nonslime producers.\[[@ref18]\] To determine the quantitative biofilm formation, microtiter plate (MTP) assay test was performed by culturing MR-CoNS isolates overnight in 96-well polystyrene tissue culture MTPs at 37°C, with Trypticase soy broth and 0.25% glucose as the growth medium. The culture medium was then removed and fixed with 95% ethanol, then stained with 1% crystal violet. Each isolate was tested in triplicate and absorbance at 570 nm was determined. Biofilm formation was interpreted as follows: highly positive (OD~570~ ≥ 1), low-grade positive (0.1 ≤ OD~570~ \< 1), or negative (OD~570~ \< 0.1).\[[@ref19]\]

Molecular detection of biofilm-associated gene {#sec2-5}
----------------------------------------------

The presence of *ica*AD, *fnb*A, and *bap* genes was detected through PCR using primers designed for MR-CoNS gene sequences from previous studies.\[[@ref13]\] Primers specific to the *cna* gene of *S. aureus* were used for amplification.\[[@ref20]\] The primer sets are shown in [Table 1](#T1){ref-type="table"}. The amplified PCR products were analyzed through electrophoresis on a 1% agarose gel.

###### 

List of primers used in this study

  Target gene   Primer                            Size (bp)   Tm (p)   Reference
  ------------- --------------------------------- ----------- -------- --------------
  *16S* rRNA    F: CGAAAGCCTGACGGAGCAAC           528         52       \[[@ref14]\]
                R: AACCTTGCGGTCGTACTCCC                                
  *tuf*         F: CCAATGCCACAAACTCGTGA           480         62       \[[@ref16]\]
                R: CAGCTTCAGCGTAGTCTAATAATTTACG                        
  *mec*A        F: TGGCTATCGTGTCACAATCG           310         58       \[[@ref21]\]
                R: CTGGAACTTGTTGAGCAGAG                                
  *ica*AD       F: GACAGTCGCTACGAAAAG             211         55       \[[@ref13]\]
                R: AATAAGCTCTCCCTAACTA                                 
  *fnb*A        F: CCCTCTTCGTTATTCAGCC            422         58       \[[@ref13]\]
                R: CAGGAGGCAAGTCACCTTG                                 
  *bap*         F: GGCGCAAGCAGCAGAATTA            901         63       \[[@ref13]\]
                R: CATAGTTCTTTGTGGTGTTGC                               
  *cna*         F: AAAGCGTTGCCTAGTGGAGA           192         55       \[[@ref20]\]
                R: AGTGCCTTCCCAAACCTTTT                                

Statistical analysis {#sec2-6}
--------------------

All data were analyzed in Excel and Stata 12.0 software (StataCorporation, College Station, TX, USA). Biofilm biomass formation by all clinical isolates was monitored based on OD~570~ values. The values were transformed to be normal distribution by a taking log. These log-transformed data were statistically analyzed using parametric statistics. The comparison of biofilm biomass production between different groups was analyzed using one-way ANOVA test. In the case of analysis among two different species group, Student\'s *t*-test was performed.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Species distribution of methicillin-resistant coagulase-negative staphylococci {#sec2-7}
------------------------------------------------------------------------------

Species-level characterization of the clinical isolates was performed by biochemical tests, PCR, MALDI-TOF-MS, and *tuf* gene sequencing. The five different species identified were *S. haemolyticus* (34.5%), *S. epidermidis* (32.7%), *Staphylococcus capitis* (18.2%), *Staphylococcus cohnii* (9.1%), and *Staphylococcus hominis* (5.5%) \[[Figure 1](#F1){ref-type="fig"}\]. The prevalence of *S. haemolyticus* was high in the clinical isolates from Chiangrai Prachanukroh Hospital, while *S. epidermidis* was predominant among MR-CoNS isolated from Naresuan University Hospital.

![Different species of methicillin-resistant coagulase-negative staphylococci isolated from hospitals in Northern Thailand](JGID-11-112-g001){#F1}

Antimicrobial susceptibility testing {#sec2-8}
------------------------------------

All MR-CoNS isolates were tested for their susceptibility against 15 commonly used antibiotics. All isolates showed the resistance to at least one antibiotic class. The isolates were resistant to oxacillin (98.2%), cefoxitin (100%), ciprofloxacin (67.3%), penicillin (98.2%), erythromycin (96.4%), sulfamethoxazole/trimethoprim (67.3%), chloramphenicol (12.7%), rifampicin (20.0%), gentamicin (67.3%), fusidic acid (23.6%), clindamycin (63.6%), mupirocin (38.2%), and novobiocin (9.1%); however, all isolates were sensitive to linezolid and vancomycin \[[Figure 2](#F2){ref-type="fig"}\].

![Drug resistance of methicillin-resistant coagulase-negative staphylococci isolated from hospitals in Northern Thailand](JGID-11-112-g002){#F2}

Determination of biofilm formation {#sec2-9}
----------------------------------

Isolates showing biofilm formation ability detected through CRA and MTP methods are indicated in [Table 2](#T2){ref-type="table"}. Using the CRA method, it was observed that seven out of 55 (12.7%) of MR-CoNS isolates formed red colonies, 27 isolates (49.1%) formed black colonies, and 21 isolates (38.2%) formed intensely black colonies. MTP assay demonstrated that 21 out of the 55 MR-CoNS isolates were biofilm producers, out of which 19 (34.5%) isolates showed low-grade positivity, 2 (3.6%) isolates showed high-grade positivity, and 34 (61.8%) isolates were nonbiofilm producers.

###### 

Presence of biofilm formation and adhesion genes in methicillin-resistant coagulase-negative staphylococci

  Biofilm formation         Clinical samples                                               
  ------------------------- ------------------ ----------- ---------- --------- ---------- -----------
  CRA                                                                                      
   Red (%)                  0                  2 (11.1)    2 (20)     3 (60)    0          7 (12.7)
   Black (%)                12 (63.2)          8 (44.4)    4 (40)     1 (20)    2 (66.7)   27 (49.1)
   Very black (%)           7 (36.8)           8 (44.4)    4 (40)     1 (20)    1 (33.3)   21 (38.2)
  MTP                                                                                      
   Negative (%)             18 (94.7)          9 (50)      1 (10)     4 (80)    2 (66.7)   34 (61.8)
   Low-grade positive (%)   1 (5.3)            7 (38.9)    9 (90)     1 (20)    1 (33.3)   19 (34.5)
   Highly positive (%)      0                  2 (11.1)    0          0         0          2 (3.6)
  Adhesion genes                                                                           
   *ica*AD (%)              0                  4 (22.2)    6 (60)     0         0          10 (18.2)
   *bap* (%)                0                  1 (5.6)     5 (50)     1 (20)    0          7 (12.7)
   *fnb*A (%)               8 (42.1)           15 (83.3)   0          3 (60)    0          26 (47.3)
   *cna* (%)                4 (21.1)           10 (55.6)   0          1 (20)    0          15 (27.3)
   *mec*A genes             19 (100)           18 (100)    10 (100)   5 (100)   3 (100)    55 (100)

*S. haemolyticus: Staphylococcus haemolyticus, S. epidermidis: Staphylococcus epidermidis, S. capitis: Staphylococcus capitis, S. cohnii: Staphylococcus cohnii, S. hominis: Staphylococcus hominis*, CRA: Congo red agar, MTP: Microtiter plate

Detection of the intracellular adhesion AD, biofilm-associated protein, fibronectin binding protein and *cna* genes {#sec2-10}
-------------------------------------------------------------------------------------------------------------------

The results given in [Table 2](#T2){ref-type="table"} indicates that the *ica*AD gene was detected in 18.2% of MR-CoNS isolates, belonging to *S. epidermidis* (22.2%) and *S. capitis* (60.0%) species, respectively. Clinical isolates of *S. haemolyticus*, *S. hominis*, and *S. cohnii* did not possess this gene. The presence of the *bap* gene was found in 12.7% of MR-CoNS isolates that belonged to *S. capitis* (50.0%), *S. cohnii* (20%), and *S. epidermidis* (5.6%), respectively. However, the *bap* gene was not detected in *S. haemolyticus* and *S. hominis*. The *fnb*A gene was present in 47.3% of MR-CoNS isolates and belonged to *S. epidermidis* (83.3%), *S. cohnii* (60%), and *S. haemolyticus* (42.1%), respectively. The *cna* gene was present in 27.3% of the MR-CoNS isolates, harbored by *S. haemolyticus* (21.1%), *S. epidermidis* (55.6%), and *S. cohnii* (20%), respectively.

Association of biofilm genotypes and biofilm biomass in Methicillin-resistant coagulase-negative staphylococci isolates {#sec2-11}
-----------------------------------------------------------------------------------------------------------------------

The biofilm biomass production (median OD~570~) of MR-CoNS isolates was investigated, and the biofilm-forming ability of each species was compared, as shown in \[[Figure 3a](#F3){ref-type="fig"}\]. The biofilm biomass of *S. epidermidis* and other species (*S. capitis*, *S. cohnii*, and *S. hominis*) were significantly higher than that of *S. haemolyticus* (*P* \< 0.05). The correlation between the presence of biofilm-associated genes and the biofilm phenotype of MR-CoNS isolates was statistically evaluated \[[Figure 3b](#F3){ref-type="fig"}\]. We found that the presence of biofilm-associated genes in MR-CoNS significantly made more biofilm biomass than strains without these biofilm-associated genes.

![Biofilm producing ability of methicillin-resistant coagulase-negative staphylococci obtained from clinical samples. (a) The comparison of OD~570~ among *Staphylococcus haemolyticus*, *Staphylococcus epidermidis*, and other staphylococcal species (*Staphylococcus capitis*, *Staphylococcus cohnii* and *Staphylococcus hominis*). (b) Comparisons of biofilm forming ability between the present and absent of biofilm-associated genes](JGID-11-112-g003){#F3}

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

MR-CoNS are the predominant cause of nosocomial infections, which greatly limit therapeutic options for opportunistic infections. It is caused by their ability to adhere the surface of biomaterials and form biofilms.\[[@ref22]\] The principal aim of the current study was to determine the prevalence of MR-CoNS species and the biofilm production of MR-CoNS isolated from hospitalized patients in Thailand. In our study, among the 55 clinically significant isolates of MR-CoNS belonging to 5 different species, *S. haemolyticus* was observed to be the most commonly distributed species. The second-most common isolate was *S. epidermidis*, followed by *S. capitis*, *S. cohnii*, and *S. hominis*, respectively. The findings agree with those of Teeraputon *et al*., who reported the prevalence MR-CoNS at Maesot Hospital, Tak province, western Thailand, and documented *S. haemolyticus* as the most prevalent species (37.55%), followed by *S. epidermidis* (21.83%), S. saprophyticus (11.79%), and *S. hominis* (11.35%), respectively.\[[@ref23]\] The prevalence of *S. haemolyticus* was found predominantly in bloodstream infections, and *S. epidermidis* was found to be one of the most prevalent pathogens implicated in catheter-related bloodstream infections. In addition, treating infections caused by MR-CoNS can be difficult due to their high level of drug resistance.\[[@ref1]\] Regarding antimicrobial susceptibility, the MR-CoNS isolates in this study showed high antibiotic resistance, especially to cefoxitin (100%), penicillin (98.2%), and erythromycin (96.4%), which is similar to MR-CoNS isolates in Thailand.\[[@ref23]\] All the 55 MR-CoNS isolates were susceptible to vancomycin and linezolid, and this result is consistent with that of the MR-CoNS isolated from clinical samples by Shrestha *et al*.\[[@ref24]\] However, some studies have reported the existence of vancomycin resistance. Mashaly and El-Mahdy (2017) observed that all the clinical isolates were susceptible to vancomycin. However, 15.5% isolates could grow on BHI agar containing 4 μg/mL vancomycin.\[[@ref25]\]

Biofilm formation remains the most important mechanism of pathogenicity among staphylococci, especially MR-CoNS. We found that 87.3% of the MR-CoNS isolated in this study were biofilm producers based on the CRA method. These results were similar to findings reported by Shrestha *et al*., which evidenced that 85% of all MR-CoNS isolated from clinical specimens were biofilm producers.\[[@ref24]\] Oliveira and Cunha Mde reported that 75% of the clinical staphylococci isolates were biofilm positive as determined by the CRA method.\[[@ref26]\] Using the MTP method to determine biofilm production, we found that 3.6% of the isolates were highly positive and 34.5% were low-grade positive. This prevalence was lower than that in the biofilm-producing MR-CoNS isolated from hospital environments, in which 66 (26.3%) isolates were highly positive and 166 (66.1%) were low-grade positive.\[[@ref13]\] However, we found that the biofilm-producing ability of MR-CoNS obtained from various species was different. The biofilm-producing ability of *S. epidermidis* and other species was significantly higher than that of *S. haemolyticus* (*P* \< 0.05). This finding correlated with the study conducted by Thilakavathy *et al*., which reported that out of the 96 MR-CoNS isolated from clinical samples, biofilm production was highest in *S. epidermidis* (38.54%) followed by S. saprophyticus (1.04%).\[[@ref27]\]

Comparing the qualitative and the quantitative methods, it was observed that CRA method is better for biofilm detection than the MTP method. All the *S. haemolyticus* isolates were identified as biofilm producers by CRA method, while 5.3% were indicated to be low-grade positive by the MTP method. A low correspondence between both methods was also demonstrated by Mathur *et al*., (2006) who showed that the screening on CRA did not correlate with the MTP screening of staphylococcal isolates.\[[@ref28]\] Several studies have evidenced that nosocomial infections caused by staphylococci is associated with the presence of biofilm-associated genes.\[[@ref10][@ref26]\] In the present study, the *ica*AD and *bap* genes were detected in 18.2% and 12.7% of MR-CoNS isolates, respectively. On the other hand, *S. haemolyticus* and *S. hominis* did not possess *ica*AD and *bap* genes. These findings correlated with the studies conducted by Seng *et al*., which demonstrated that *S. haemolyticus* and other species of staphylococci isolated from community environments did not possess *ica*AD and *bap* genes.\[[@ref13]\] All of *S. capitis* isolates that possessed *ica*AD genes formed biofilms as detected by the MTP and CRA methods, while *S. haemolyticus*, *S. hominis*, and *S. cohnii* that have the ability to produce biofilm when assessed by the CRA method lack the *ica*AD gene. The biofilm-forming ability of some isolates in absence of *ica*AD gene, as detected by the CRA method, indicates that they form biofilm through icaAD-independent mechanisms.\[[@ref29]\]

Regarding the important role of genes associated with biofilm biomass production, the *ica*AD gene was found to be involved in biofilm formation, while the *bap*, *fnb*A, and *cna* genes were found to play a role in attachment to biotic or abiotic surfaces, which represents the first step of the process of biofilm formation.\[[@ref8]\] In this study, 61.82% of the isolates that harbored *ica*AD, *bap*, *fnb*A, and *cna* genes alone or in combination were found to produce biofilm significantly via the MTP method. These results were in accordance with the study conducted by Oliveira and Cunha Mde, who demonstrated that 81% of the isolates were positive in the Tissue culture plate test and showed the presence of the *ica*AD genes.\[[@ref26]\] Similarly, the study conducted by Nasr *et al*. demonstrated that 50% of the *ica*AD-positive isolates were found to be positive for biofilm formation through the MTP method.\[[@ref30]\] In addition, this study indicated that the *fnb*A gene is present in 47.3% of MR-CoNS isolates. These findings correlated with studies conducted by Giormezis *et al*., who detected the *fnb*A gene in 41.4% of biofilm-producing isolates from patients exhibiting bloodstream infections.\[[@ref31]\] However, this study concluded that the CRA method might be less precise for the identification of biofilm-forming isolates when compared to PCR, which is used for the detection of the genes involved in biofilm production.

C[ONCLUSION]{.smallcaps} {#sec1-5}
========================

All MR-CoNS were belonged to different species, and all the isolates were observed to be multidrug-resistant bacteria. The presence of biofilm associated-genes was detected in the MR-CoNS isolates, and this study has demonstrated an association between biofilm-associated genes and the biofilm phenotype of MR-CoNS isolates. These results represent an important area for further research, and the regulation of biofilm expression is in need to play a central role in the disease prevention.
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